31.61USD+0.33%Mkt Cap: 1.84B USDP/E: 12.80Last update: 2026-06-01
Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare neurological diseases in the United States. The company offers WAK…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap1.84B USD
Enterprise Value1.35B USD
Revenue (TTM)899.11M USD
Gross Profit670.11M USD
Net Income (TTM)158.69M USD
Revenue/Share15.60 USD
Last Price31.61 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees293
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)12.80
P/E (Forward)5.66
PEG—
EV/EBITDA6.29
EV/Revenue1.50
P/S2.03
P/B2.01
EPS (TTM)2.48
EPS (Forward)5.58
52W Range
25.5240% of range40.87
52W High40.87 USD
52W Low25.52 USD
Profitability
Gross Margin77.16%
Oper. Margin17.31%
EBITDA Margin23.90%
Profit Margin18.27%
ROE18.24%
ROA12.48%
Growth
Revenue Growth16.60%
Earnings Growth-29.50%
Cash Flow & Leverage
Operating CF348.20M USD
CapEx (TTM)310.00K USD
FCF Margin16.65%
FCF Yield8.15%
Net Debt-476.31M USD
Net Debt/EBITDA-2.22
Balance Sheet
Debt/Equity0.19
Current Ratio3.58
Quick Ratio3.45
Book Value/Sh15.73 USD
Cash/Share11.07 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)44.36 USD
Target Range28.00 USD – 85.00 USD
# Analysts11
Ownership
Shares Out.57.89M
Float51.73M
Insiders11.69%
Institutions103.39%
Short Interest
Short Ratio7.1d
Short % Float15.30%
Short % Out.11.43%
Shares Short6.62M
Short (prev mo.)7.29M
Technical
SMA 5029.77 (+6.2%)
SMA 20032.58 (-2.9%)
Beta0.96
S&P 52W Chg27.94%
Avg Vol (30d)836.67K
Avg Vol (10d)623.12K
Technical Indicators
RSI (14)56.5
MACD0.1501
MACD Signal0.1422
MACD Hist.+0.0079
BB Upper32.75 USD
BB Middle31.01 USD
BB Lower29.27 USD
BB Width11.25%
ATR (14)1.026 USD
Vol Ratio (20d)0.75x